The procedures used for in vivo mouse tumor inhibition tests generally followed the protocols Table 1 . Effect of kijanimicin on P-388 lymphatic established by the National Cancer Institute'). Kijanimicin, which is water soluble, was dissolved in saline and injected intraperitoneally into tumor bearing mice according to the schedules shown on the accompanying tables.
The results of a test in which kijanimicin was administered on three different dose schedules to mice bearing P-388 leukemia are shown in Table 1 . The maximum survival increase, T/C= 156, was observed at 32 mg/kg/day on a daily x 9 schedule. Using the same schedule, slight inhibition of B16 melanoma was also seen, 
